Protagonist Therapeutics, Inc. (PTGX)

Nasdaq · Healthcare · Biotechnology
$121.40-2.11%As of 2026-11-22 · USD
Last session low $120.15Last session high $125.74
52-week low $77.0052-week high $160.81
Market cap
$7.92B
Sector
Healthcare
P/E (TTM)
25.7x

Market data and research context for informational purposes. Not investment advice.

Technical indicators

Indicators from the 2026-11-20 daily bar; Bollinger %B and the average rows compare the latest price with those values. Prices in USD.

IndicatorValueReading
RSI (14)32.8In the neutral range (30 to 70)
MACD (12, 26, 9)-4.15Below its signal line (-2.77); histogram -1.38
Bollinger %B (20, 2)2%Inside the bands (120.89 to 148.99)
SMA 20134.94Price is 10.0% below
SMA 50138.17Price is 12.1% below
SMA 200120.34Price is 0.9% above
ATR (20)4.60% of priceAverage true range per day
52-week position53%In the middle of the 77.00 to 160.81 range

About Protagonist Therapeutics, Inc.

Protagonist Therapeutics, Inc. operates as a discovery and development company in the United States.

Insider filings, 90 daysNo purchases and 5 sales (about $26.9M).
Latest fiscal yearEnded 2025-12-31: revenue of $46.02M and an operating margin of -343.6%.

More in Biotechnology